INS and breast cancer: In this study, the lncRNAs ARRDC1-AS1 and MIRLET7BHG could coexpress with FASN to be involved in “insulin signaling pathway.” The lncRNA ARRDC1-AS1 was involved in a 9-lncRNA signature to predict recurrence of breast cancer [32].